Evidence map›Paper›PMID 40520521›Full record

ArticleToxicology reports2025

Unveiling the molecular interactions between bisphenol A and the cell surface Toll-like receptors: Implications for immune health.

Prem Rajak, Abhratanu Ganguly

Abstract read
In one paragraph

Article in Toxicology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Prem RajakToxicology Research Laboratory, Department of Animal Science, Kazi Nazrul University, Asansol, West Bengal, India.
Abhratanu GangulyToxicology Research Laboratory, Department of Animal Science, Kazi Nazrul University, Asansol, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microplastic pollution is an emerging threat to the human health. In nature, microplastics release several compounds of toxicological importance. Among them, bisphenol A (BPA), a widely used additive in plastic production, is an important one. Upon breakdown, microplastics release significant amounts of BPA in air, water, and soil. Humans may be exposed to BPA through nasal, oral, and dermal routes. BPA is linked to oxidative stress, physiological disturbance, and chronic diseases. Moreover, it may target the immune system. Toll-like receptors (TLRs) are important mediators of both innate and adaptive immunity and recognize microbial signature molecules to trigger signaling cascades employed in anti-microbial defense mechanism. Inhibition of TLR-mediated signaling can result in compromised immunity. Hence, the present work aims to investigate the inhibitory potential of BPA against cell surface TLRs. For this study, a molecular docking approach using the AutoDock vina algorithm was employed to analyze the docking potential of BPA with the surface-associated TLRs. Results have revealed that BPA binds to TLR1, TLR2, TLR4, TLR5, and TLR6 with affinity ranging from -4.3 to -7.3 kcal/mol. Structural analyses of the docked complexes have suggested that BPA binds to TLR through conventional H-bonds. Van der Waals and other hydrophobic interactions further stabilized the docked complexes. Notably, C-H bonds were also apparent in some docked conformations. Hence, results of the present study equivocally suggest that BPA can potentially bind to the cell surface TLRs through various bonds and interactions. Such interactions may modulate TLR-mediated signaling and immunity in organisms.

Indexed as

Bisphenol ACompromised immunityMicroplasticsToll-like receptor

Identifiers

PMID40520521
PMCPMC12163412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.